Literature DB >> 25934566

The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats.

Daniela Impellizzeri1, Akbar Ahmad1, Giuseppe Bruschetta1, Rosanna Di Paola1, Rosalia Crupi1, Irene Paterniti1, Emanuela Esposito1, Salvatore Cuzzocrea2.   

Abstract

The aim of this study was to investigate the effects of palmitoylethanolamide (PEA), an endogenous fatty acid amide belonging to the family of the N-acylethanolamines (NAEs), in rats subjected to endotoxin-induced uveitis (EIU). EIU was induced in male rats by a single footpad injection of 200μg lipopolysaccharide (LPS). PEA was administered intraperitoneally at 1h before and 7h after injection of LPS. Another group of animals was treated with vehicle. Dexamethasone (DEX) was administered as a positive control. Rats were sacrificed 16h after injection and the eyes tissues were collected for histology, immunohistochemical and western blot analyses. The histological evaluation of the iris-ciliary body showed an increase of neutrophilic infiltration and nuclear modification of vessel of endothelial cells. PEA treatment decreased the inflammatory cell infiltration and improved histological damage of eye tissues. In addition, PEA treatment reduced pro-inflammatory tumor necrosis factor (TNF-α) levels, protein extravasion and lipid peroxidation. Immunohistochemical analysis for intracellular adhesion molecule (ICAM)-1 and nitrotyrosine showed a positive staining from LPS-injected rats. The degree of staining for ICAM-1 and nitrotyrosine was significantly reduced in eye sections from LPS-injected rats treated with PEA. In addition, an increase of inducible nitric oxide synthase (iNOS) and nuclear factor (NF-κB) was also evaluated in inflammed ocular tissues by western blot. PEA strongly inhibited iNOS expression and nuclear NF-κB translocation. Thus, in this study we demonstrated that PEA reduces the degree of ocular inflammation in a rat model of EIU.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytokines; Inflammation; N-palmitoylethanolamide (PEA); Neutrophils; Oxidative stress; Uveitis

Mesh:

Substances:

Year:  2015        PMID: 25934566     DOI: 10.1016/j.ejphar.2015.04.025

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy.

Authors:  Jie Shen; Yuanqing Ye; David W Chang; Maosheng Huang; John V Heymach; Jack A Roth; Xifeng Wu; Hua Zhao
Journal:  Lung Cancer       Date:  2017-11-02       Impact factor: 5.705

Review 2.  The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.

Authors:  Stefania Petrosino; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2016-09-29       Impact factor: 8.739

3.  Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats.

Authors:  Masatsugu Ohara; Shunsuke Ohnishi; Hidetaka Hosono; Koji Yamamoto; Qingjie Fu; Osamu Maehara; Goki Suda; Naoya Sakamoto
Journal:  Front Pharmacol       Date:  2018-07-13       Impact factor: 5.810

Review 4.  ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain.

Authors:  Ramona D'Amico; Daniela Impellizzeri; Salvatore Cuzzocrea; Rosanna Di Paola
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

Review 5.  Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy.

Authors:  Jan M Keppel Hesselink; Ciro Costagliola; Josiane Fakhry; David J Kopsky
Journal:  J Ophthalmol       Date:  2015-11-18       Impact factor: 1.909

6.  Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats.

Authors:  Francisco Javier Pavón; Eva María Marco; Mariam Vázquez; Laura Sánchez; Patricia Rivera; Ana Gavito; Virginia Mela; Francisco Alén; Juan Decara; Juan Suárez; Elena Giné; José Antonio López-Moreno; Julie Chowen; Fernando Rodríguez-de-Fonseca; Antonia Serrano; María Paz Viveros
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

7.  Editorial. New Targets of Medical Treatment in Psychiatric Disorders.

Authors:  Kunio Yui
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

8.  A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models.

Authors:  Domenico Britti; Rosalia Crupi; Daniela Impellizzeri; Enrico Gugliandolo; Roberta Fusco; Carlo Schievano; Valeria Maria Morittu; Maurizio Evangelista; Rosanna Di Paola; Salvatore Cuzzocrea
Journal:  BMC Vet Res       Date:  2017-08-02       Impact factor: 2.741

Review 9.  Endocannabinoid-related compounds in gastrointestinal diseases.

Authors:  Marcella Pesce; Alessandra D'Alessandro; Osvaldo Borrelli; Stefano Gigli; Luisa Seguella; Rosario Cuomo; Giuseppe Esposito; Giovanni Sarnelli
Journal:  J Cell Mol Med       Date:  2017-10-09       Impact factor: 5.310

10.  High drug payload nanoparticles formed from dexamethasone-peptide conjugates for the treatment of endotoxin-induced uveitis in rabbit.

Authors:  Xinxin Yu; Renshu Zhang; Lei Lei; Qianqian Song; Xingyi Li
Journal:  Int J Nanomedicine       Date:  2019-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.